<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Biotechnology: News &amp; Videos about Biotechnology - CNN.com</title><link>http://topics.cnn.com/topics/feeds/rss/Biotechnology</link><description>Find stories, videos, and photos about Biotechnology from CNN.com.</description><language>en-us</language><copyright>Cable News Network LP, LLLP.</copyright><pubDate>Thu, 26 Nov 2009 06:54:32 GMT</pubDate><ttl>5</ttl><image><title>Biotechnology: News &amp; Videos about Biotechnology - CNN.com</title><url>http://i.cdn.turner.com/cnn/.element/img/1.0/logo/cnn.logo.rss.gif</url><link>http://topics.cnn.com/topics/feeds/rss/Biotechnology</link><width>144</width><height>33</height><description>Find stories, videos, and photos about Biotechnology from CNN.com.</description></image><item><title>Teva: The king of generic drugs</title><link>http://money.cnn.com/2009/08/04/news/companies/generic_drugs_pharmaceutical.fortune/index.htm</link><guid>http://money.cnn.com/2009/08/04/news/companies/generic_drugs_pharmaceutical.fortune/index.htm</guid><description>No one knows what the CEOs of the biggest drug companies dream about, but their nightmares probably look a little like this:</description><pubDate>Wed, 05 Aug 2009 16:35:00 EDT</pubDate></item><item><title>The Obama biotech boost</title><link>http://money.cnn.com/2009/07/23/markets/thebuzz/index.htm</link><guid>http://money.cnn.com/2009/07/23/markets/thebuzz/index.htm</guid><description>Fears about what President Obama's health care reform plan may do to the earnings of drugmakers has caused many Big Pharma stocks to come down with the sickness this year.</description><pubDate>Thu, 23 Jul 2009 17:26:00 EDT</pubDate></item><item><title>Making big drugs during troubled times</title><link>http://money.cnn.com/2009/07/08/news/companies/amgen_kevin_sharer_biotech_pharmaceuticals.fortune/index.htm</link><guid>http://money.cnn.com/2009/07/08/news/companies/amgen_kevin_sharer_biotech_pharmaceuticals.fortune/index.htm</guid><description>These are momentous times for Amgen, the world's largest biotech company. The health-care revolution brewing in Washington could be dramatically good news or bad for a business whose drugs tend to be life-changing -- and highly expensive. Also on deck this year is a critical FDA decision on Amgen's denosumab, a possible blockbuster treatment for osteoporosis and bone cancer on which Amgen is betting heavily. If it's approved, analysts expect annual sales of at least $1 billion -- maybe double or triple that. Overseeing it all is CEO Kevin Sharer, 61, who joined the company 17 years ago as a newcomer to biotech after a career with the U.S. Navy, McKinsey, General Electric, among others. Amgen stock has been up and down during his nine years as chief, but right now Wall Street likes its prospects: 19 analysts rate it a buy or a strong buy, based on denosumab's prospects and further operating efficiencies, while five say it's a hold in light of the recession and strengthening</description><pubDate>Thu, 09 Jul 2009 16:54:00 EDT</pubDate></item><item><title>FDA issues final guidelines for genetically engineered animals</title><link>http://www.cnn.com/2009/HEALTH/01/15/genetically.modified.animals/index.html#cnnSTCText</link><guid>http://www.cnn.com/2009/HEALTH/01/15/genetically.modified.animals/index.html#cnnSTCText</guid><description>The Food and Drug Administration announced formal guidelines Thursday that will regulate the production of genetically engineered (GE) animals.</description><pubDate>Thu, 15 Jan 2009 19:44:00 EST</pubDate></item><item><title>Is cloned meat safe?</title><link>http://www.cnn.com/2008/HEALTH/dailydose/11/21/cloned.meat.safety/index.html#cnnSTCText</link><guid>http://www.cnn.com/2008/HEALTH/dailydose/11/21/cloned.meat.safety/index.html#cnnSTCText</guid><description>Soon, the food you put on your dinner table may be from cloned animals and chances are, you won't even know it. The Food and Drug Administration announced in January 2008 that's it OK to sell meat and milk from cloned cattle, pigs and goats. What does this mean to the consumer? Is cloned meat safe? How does it differ from regular animal products?</description><pubDate>Mon, 22 Dec 2008 17:58:00 EST</pubDate></item><item><title>Gene therapy aids vision for 3 with rare blindness</title><link>http://www.cnn.com/2008/HEALTH/dailydose/11/20/genetic.treatment.blindness/index.html#cnnSTCText</link><guid>http://www.cnn.com/2008/HEALTH/dailydose/11/20/genetic.treatment.blindness/index.html#cnnSTCText</guid><description>Researchers at the University of Pennsylvania announced in April 2008 the use of an innovative gene therapy treatment to safely restore vision in three adults with a rare form of congenital blindness. The technique involves an injection that delivers DNA to the nucleus of a cell so it can begin making the protein that the blind patients don't have. Although the patients have not achieved normal eyesight, the results set the stage for possible treatment of other retinal diseases.</description><pubDate>Mon, 22 Dec 2008 17:53:00 EST</pubDate></item><item><title>Synthetic biology inches toward the mainstream</title><link>http://www.cnn.com/2008/TECH/10/17/digitalbiz.synbio/index.html#cnnSTCText</link><guid>http://www.cnn.com/2008/TECH/10/17/digitalbiz.synbio/index.html#cnnSTCText</guid><description>As bioengineers continue to build things with the stuff of life itself, the rest of the world is slowly waking up to the power of synthetic biology.</description><pubDate>Mon, 20 Oct 2008 07:36:00 EDT</pubDate></item><item><title>Steroids In America: The Future</title><link>http://sportsillustrated.cnn.com/2008/magazine/03/11/steroids.future/index.html</link><guid>http://sportsillustrated.cnn.com/2008/magazine/03/11/steroids.future/index.html</guid><description>I am one of the most avid sports fans you'll find," Se-Jin Lee says. It's true. He'll watch anything. Basketball. Football. Fútbol. Billiards on channel seven-hundred-whatever. As a graduate student in the '80s Lee used to sit in his car in the driveway with the radio on to listen to the games of faraway baseball teams. Even now, in his lab at Johns Hopkins Medical School in Baltimore, he easily rattles off the NCAA basketball tournament winners in order from 1964 to 2007. And, like anyone who values fair competition these days, he's disturbed by the issue of performance-enhancing drugs in sports.</description><pubDate>Wed, 12 Mar 2008 14:52:00 EDT</pubDate></item><item><title>China's Genetically Altered Food Boom
 
 
 
</title><link>http://www.time.com/time/health/article/0,8599,1714218,00.html?xid=feed-cnn-topics</link><guid>http://www.time.com/time/health/article/0,8599,1714218,00.html?xid=feed-cnn-topics</guid><description>China is gearing up to dominate the genetically modified crop game. And the West is increasingly worried about monitoring these products around the globe</description><pubDate>Mon, 18 Feb 2008 15:15:00 EST</pubDate></item><item><title>FDA OKs meat, milk from most cloned animals</title><link>http://www.cnn.com/2008/HEALTH/01/15/fda.cloning/index.html#cnnSTCText</link><guid>http://www.cnn.com/2008/HEALTH/01/15/fda.cloning/index.html#cnnSTCText</guid><description>Food from healthy clones of cattle, swine and goats is as safe as food from non-cloned animals, the Food and Drug Administration said in a report released Tuesday.</description><pubDate>Tue, 15 Jan 2008 21:42:00 EST</pubDate></item><item><title>Here come the clones</title><link>http://money.cnn.com/2008/01/15/technology/simons_clones.fortune/index.htm</link><guid>http://money.cnn.com/2008/01/15/technology/simons_clones.fortune/index.htm</guid><description>In a long-awaited and controversial decision, the Food and Drug Administration announced Tuesday that food products derived from cloned cattle, swine, goats, sheep and their offspring are safe enough to enter the U.S. food supply.</description><pubDate>Tue, 15 Jan 2008 20:45:00 EST</pubDate></item><item><title>Send in the clones</title><link>http://money.cnn.com/2008/01/08/technology/simons_clones.fortune/index.htm</link><guid>http://money.cnn.com/2008/01/08/technology/simons_clones.fortune/index.htm</guid><description>As early as Tuesday, the FDA is likely to issue U.S. food producers an approval to begin selling meat and dairy from cloned animals and their offspring.</description><pubDate>Tue, 08 Jan 2008 19:37:00 EST</pubDate></item><item><title>You, again: Are we getting closer to cloning humans?</title><link>http://www.cnn.com/2007/WORLD/europe/11/16/ww.humancloning/index.html#cnnSTCText</link><guid>http://www.cnn.com/2007/WORLD/europe/11/16/ww.humancloning/index.html#cnnSTCText</guid><description>Ever wanted to be a new you? Recent developments in cloning mean that day might be possible without therapy, a new diet or fitness regime. </description><pubDate>Mon, 19 Nov 2007 08:34:00 EST</pubDate></item><item><title>Why the biotech party is winding down</title><link>http://money.cnn.com/2007/09/05/magazines/fortune/simons_biosimilar.fortune/index.htm</link><guid>http://money.cnn.com/2007/09/05/magazines/fortune/simons_biosimilar.fortune/index.htm</guid><description>For three decades, biotech drugmakers have led a charmed existence. Unlike their Big Pharma peers, biotechs - companies such as Amgen, Genentech, Gilead Sciences and Genzyme - have never had to fret over future competition from generic versions of their medicines.</description><pubDate>Wed, 05 Sep 2007 06:56:00 EDT</pubDate></item><item><title>UK to go ahead with hybrid embryos</title><link>http://www.cnn.com/2007/WORLD/europe/09/05/hybrid.embryos.ap/index.html#cnnSTCText</link><guid>http://www.cnn.com/2007/WORLD/europe/09/05/hybrid.embryos.ap/index.html#cnnSTCText</guid><description>British authorities ruled Wednesday that research using animal eggs to create human stem cells could go forward in principle.</description><pubDate>Wed, 05 Sep 2007 04:58:00 EDT</pubDate></item><item><title>Super trees: The latest in genetic engineering</title><link>http://money.cnn.com/2007/07/31/technology/pluggedin_gunther_supertrees.fortune/index.htm</link><guid>http://money.cnn.com/2007/07/31/technology/pluggedin_gunther_supertrees.fortune/index.htm</guid><description>In 1913, the New Jersey poet and critic Joyce Kilmer wrote "Trees," a poem which concludes with this simple rhyme:</description><pubDate>Mon, 27 Aug 2007 04:10:00 EDT</pubDate></item><item><title>Troubled Amgen's pipeline dreams</title><link>http://money.cnn.com/2007/07/06/news/companies/amgen/index.htm</link><guid>http://money.cnn.com/2007/07/06/news/companies/amgen/index.htm</guid><description>Amgen, king of the biotechs, sits on a shaky throne.</description><pubDate>Fri, 06 Jul 2007 07:21:00 EDT</pubDate></item><item><title>Attack of the mutant rice</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2007/07/09/100122123/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2007/07/09/100122123/index.htm</guid><description>Back in the spring of 2001, a 64-year-old Texas rice farmer named Jacko Garrett watched a fleet of 18-wheelers haul away truckloads of rice that he had grown with great care. "It just bothers me so bad," Garrett said. "I'm sitting here trying to find food to feed people, and I've got to bury five million pounds of rice." No one likes to waste food, but for Garrett, who runs a charity that collects rice for the needy, the pain was especially acute.</description><pubDate>Mon, 02 Jul 2007 07:56:00 EDT</pubDate></item><item><title>A Gene to Cure Blindness</title><link>http://www.time.com/time/health/article/0,8599,1623086,00.html?xid=feed-cnn-topics</link><guid>http://www.time.com/time/health/article/0,8599,1623086,00.html?xid=feed-cnn-topics</guid><description>A procedure that replaces faulty genes in the blind might hold cures for all kinds of genetic diseases and for cancer</description><pubDate>Fri, 25 May 2007 19:40:00 EDT</pubDate></item><item><title>India's elephant in the room: Weak patent laws</title><link>http://money.cnn.com/2007/05/04/news/companies/india_biotech/index.htm</link><guid>http://money.cnn.com/2007/05/04/news/companies/india_biotech/index.htm</guid><description>India's fast-growing biotech business has the potential to be one of the driving forces behind its enviable 8 percent GDP growth, and a government estimate sees the industry increasing 15-fold over the next eight years.</description><pubDate>Fri, 04 May 2007 14:24:00 EDT</pubDate></item><item><title>The bill that could rock biotech</title><link>http://money.cnn.com/2007/04/30/news/biogenerics/index.htm</link><guid>http://money.cnn.com/2007/04/30/news/biogenerics/index.htm</guid><description>Lawmakers are pushing forward with legislation that could help create generic competition for Big Biotech, drastically lowering the costs of expensive biotech drugs and changing the landscape in the pharmaceutical industry forever.</description><pubDate>Mon, 30 Apr 2007 09:54:00 EDT</pubDate></item><item><title>Congress said to want cheaper biotech drugs</title><link>http://money.cnn.com/2007/04/07/news/congress_biotechs/index.htm</link><guid>http://money.cnn.com/2007/04/07/news/congress_biotechs/index.htm</guid><description>Senior Democrats and Republicans in Congress are hard at work on bills that would provide millions of Americans with cheaper copies of biotech drugs that can cost hundreds of thousands of dollars a year, a news report said Saturday.</description><pubDate>Sun, 08 Apr 2007 00:44:00 EDT</pubDate></item><item><title>Generic drugs concoct their next move</title><link>http://money.cnn.com/2007/02/09/news/companies/generics/index.htm</link><guid>http://money.cnn.com/2007/02/09/news/companies/generics/index.htm</guid><description>Generic drugmakers, fresh off a profitable and product-heavy year, will seek future growth in fast-growing markets outside the U.S. and the burgeoning  expiration of biotechnology patents, according to analysts.</description><pubDate>Fri, 09 Feb 2007 15:30:00 EST</pubDate></item><item><title>Will Africa cotton to bioengineering?</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2007/01/22/8398210/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2007/01/22/8398210/index.htm</guid><description>Lorence Nyaka hacks at the root of a cassava plant, slicing away one fresh tuber after another until he has a small pile, enough to make a midday meal for his wife and three young children.</description><pubDate>Mon, 29 Jan 2007 22:43:00 EST</pubDate></item><item><title>Genentech to unveil more on key cancer drug</title><link>http://money.cnn.com/2007/01/19/news/companies/genentech/index.htm</link><guid>http://money.cnn.com/2007/01/19/news/companies/genentech/index.htm</guid><description>Genentech will unveil new details this weekend on tests of Avastin, one of its biggest-selling medicines, as it seeks to find new markets for the cancer drug.</description><pubDate>Fri, 19 Jan 2007 19:07:00 EST</pubDate></item><item><title>Stem cell scandal shocks South Korea</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2006/12/25/8396782/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2006/12/25/8396782/index.htm</guid><description>Last year, Hwang Woo-suk was Korea's scientific Superman. He had three institutes, a stamp created in his honor, and, over the years, $60 million at his disposal. His face was plastered on buses in... </description><pubDate>Fri, 22 Dec 2006 11:40:00 EST</pubDate></item><item><title>Life at 140? Longer life spans up for debate</title><link>http://www.cnn.com/2006/HEALTH/11/27/long.life/index.html</link><guid>http://www.cnn.com/2006/HEALTH/11/27/long.life/index.html</guid><description>Imagine a world with no cancer, Alzheimer's disease or diabetes, where people routinely live to be 140 years old.</description><pubDate>Mon, 27 Nov 2006 17:52:00 EST</pubDate></item><item><title>The making of Gardasil</title><link>http://money.cnn.com/2006/11/22/news/companies/gardasil/index.htm</link><guid>http://money.cnn.com/2006/11/22/news/companies/gardasil/index.htm</guid><description>On the site of a former amusement park in a small Pennsylvania town, technicians sheathed in plastic suits labor over stainless steel fermentation tanks that look like brewery vats.</description><pubDate>Wed, 22 Nov 2006 15:24:00 EST</pubDate></item><item><title>Biotech stocks in the dog house</title><link>http://money.cnn.com/2006/10/02/news/companies/biotech/index.htm</link><guid>http://money.cnn.com/2006/10/02/news/companies/biotech/index.htm</guid><description>It wasn't that long ago that fast-rising biotech stocks were selling for boutique prices. Well, those days are done, and biotech's slumping performance this year has put them within reach of the bargain bin.</description><pubDate>Mon, 02 Oct 2006 16:32:00 EDT</pubDate></item><item><title>Big Pharma's biotech strategy: Buy it</title><link>http://money.cnn.com/2006/09/21/news/companies/mergers/index.htm</link><guid>http://money.cnn.com/2006/09/21/news/companies/mergers/index.htm</guid><description>Question: You are a big, behemoth drug company with a maturing set of products, little in the way of new research horizons, and generic competition nipping at your heals. What do you do?</description><pubDate>Thu, 21 Sep 2006 18:17:00 EDT</pubDate></item><item><title>Barr's risky $2.5 billion bid for biogenerics</title><link>http://money.cnn.com/2006/09/15/news/companies/barr/index.htm</link><guid>http://money.cnn.com/2006/09/15/news/companies/barr/index.htm</guid><description>Generic drug giant Barr Pharmaceuticals is trying to buy its way into the biogenerics industry.</description><pubDate>Fri, 15 Sep 2006 17:19:00 EDT</pubDate></item><item><title>Missing the $20 billion biogeneric boom</title><link>http://money.cnn.com/2006/08/14/news/companies/biogenerics/index.htm</link><guid>http://money.cnn.com/2006/08/14/news/companies/biogenerics/index.htm</guid><description>A huge new industry - biogenerics - is waiting to be born.</description><pubDate>Mon, 14 Aug 2006 17:22:00 EDT</pubDate></item><item><title>Amgen tops forecasts</title><link>http://money.cnn.com/2006/07/20/news/companies/amgen/index.htm</link><guid>http://money.cnn.com/2006/07/20/news/companies/amgen/index.htm</guid><description>Amgen Inc. Thursday reported a surge in second-quarter earnings and sales, soundly beating Wall Street forecasts.</description><pubDate>Thu, 20 Jul 2006 19:56:00 EDT</pubDate></item><item><title>CNN Future Summit forum</title><link>http://www.cnn.com/2006/TECH/science/04/28/fs.GMprotest.forum/index.html</link><guid>http://www.cnn.com/2006/TECH/science/04/28/fs.GMprotest.forum/index.html</guid><description>"Would you or do you eat G.M. food?"</description><pubDate>Fri, 28 Apr 2006 09:41:00 EDT</pubDate></item><item><title>The food of the future?</title><link>http://www.cnn.com/2006/TECH/science/04/28/gmcropcontr/index.html</link><guid>http://www.cnn.com/2006/TECH/science/04/28/gmcropcontr/index.html</guid><description>Putting fish genes in plants? It's messing with nature, isn't it?</description><pubDate>Fri, 28 Apr 2006 08:29:00 EDT</pubDate></item><item><title>Drug giants get the upper hand -- for now</title><link>http://money.cnn.com/2006/04/17/news/companies/drug_biotech/index.htm</link><guid>http://money.cnn.com/2006/04/17/news/companies/drug_biotech/index.htm</guid><description>Remember way back in 2005, when Big Pharma was the whipping boy, but biotech stocks were so hot they could do no wrong?</description><pubDate>Mon, 17 Apr 2006 13:50:00 EDT</pubDate></item><item><title>Biotechs reach all-time sales high in 2005</title><link>http://money.cnn.com/2006/04/04/news/companies/biotechs/index.htm</link><guid>http://money.cnn.com/2006/04/04/news/companies/biotechs/index.htm</guid><description>The worldwide biotech industry is bigger than ever, with revenues exceeding $60 billion for the first time in the industry's 30-year history, according to a report released Tuesday.</description><pubDate>Tue, 04 Apr 2006 13:41:00 EDT</pubDate></item><item><title>More good times ahead for biotechs</title><link>http://money.cnn.com/2006/02/23/news/companies/drug_sales/index.htm</link><guid>http://money.cnn.com/2006/02/23/news/companies/drug_sales/index.htm</guid><description>Drug sales, bolstered by Medicare coverage, are projected to keep rising for the next 10 years, and  biotechs are expected to get the lion's share of that increase, while the more traditional Big Pharma companies get squeezed by generic drug makers.</description><pubDate>Thu, 23 Feb 2006 14:21:00 EST</pubDate></item><item><title>Good times ahead for biotechs</title><link>http://money.cnn.com/2006/02/22/news/companies/drug_sales/index.htm</link><guid>http://money.cnn.com/2006/02/22/news/companies/drug_sales/index.htm</guid><description>Drug sales, bolstered by Medicare coverage, are projected to keep rising for the next 10 years, and  biotechs are expected to get the lion's share of that increase, while the more traditional Big Pharma companies get squeezed by generic drug makers.</description><pubDate>Wed, 22 Feb 2006 19:55:00 EST</pubDate></item><item><title>Biotechs may be a good bet for 2006</title><link>http://money.cnn.com/2005/12/21/news/midcaps/biotech/index.htm</link><guid>http://money.cnn.com/2005/12/21/news/midcaps/biotech/index.htm</guid><description>Investors who stuck with their biotech stocks this year are sitting pretty but will the good times roll through 2006?</description><pubDate>Wed, 21 Dec 2005 11:55:00 EST</pubDate></item><item><title>CAN FRIST HOLD THE MIDDLE GROUND?</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2005/09/05/8271395/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2005/09/05/8271395/index.htm</guid><description>WHEN SENATE MAJORITY LEADER Bill Frist backed a bill to expand the number of federally funded stem-cell lines a few weeks ago, he laid claim to something increasingly rare in America's polarized "e...</description><pubDate>Mon, 05 Sep 2005 04:01:00 EDT</pubDate></item><item><title>Betting the Farm</title><link>http://money.cnn.com/magazines/business2/business2_archive/2005/09/01/8356513/index.htm</link><guid>http://money.cnn.com/magazines/business2/business2_archive/2005/09/01/8356513/index.htm</guid><description>Deep in the bowels of Monsanto's sprawling headquarters' research complex, in a room protected by a heavy steel door, 672 corn seedlings repose in plastic trays. The temperature in the room, known ...</description><pubDate>Thu, 01 Sep 2005 04:01:00 EDT</pubDate></item><item><title>Frist stem cell support boosts biotechs</title><link>http://money.cnn.com/2005/07/29/news/midcaps/biotech/index.htm</link><guid>http://money.cnn.com/2005/07/29/news/midcaps/biotech/index.htm</guid><description>NEW YORK (CNN/Money) - Biotech stock prices surged after Senate Majority Leader Bill Frist stated his support for a bill that would provide federal funding for stem cell research, but analysts urged investor caution even as they hailed the good news.</description><pubDate>Fri, 29 Jul 2005 15:43:00 EDT</pubDate></item><item><title>Biotech revenue, losses up</title><link>http://money.cnn.com/2005/06/01/news/midcaps/ernst/index.htm</link><guid>http://money.cnn.com/2005/06/01/news/midcaps/ernst/index.htm</guid><description>The biotechnology sector continued to lose money last year, even as its sales increased, according to a report released Wednesday by the accounting firm Ernst &amp;amp; Young.</description><pubDate>Wed, 01 Jun 2005 16:19:00 EDT</pubDate></item><item><title>Genetically modified cats for sale</title><link>http://www.cnn.com/2004/TECH/10/27/biotechnology.cats/index.html</link><guid>http://www.cnn.com/2004/TECH/10/27/biotechnology.cats/index.html</guid><description>A California biotechnology company has started taking orders for a hypoallergenic cat for pet lovers prone to allergies.</description><pubDate>Wed, 27 Oct 2004 13:07:00 EDT</pubDate></item><item><title>Chairman of Biocon, Kiran Mazumdar-Shaw TalkAsia Interview Transcript</title><link>http://www.cnn.com/2004/WORLD/asiapcf/09/13/talkasia.mazumdar-shaw.script/index.html</link><guid>http://www.cnn.com/2004/WORLD/asiapcf/09/13/talkasia.mazumdar-shaw.script/index.html</guid><description>Airdate: September 4th 2004.</description><pubDate>Mon, 13 Sep 2004 07:21:00 EDT</pubDate></item><item><title>Does it Pay to Bet on Biotech? For every Amgen or Genentech, 24 other beaker babies never earn a dime. But some very specific kn</title><link>http://money.cnn.com/magazines/business2/business2_archive/2004/09/01/379494/index.htm</link><guid>http://money.cnn.com/magazines/business2/business2_archive/2004/09/01/379494/index.htm</guid><description>It's hard to find a riskier bunch of stocks than biotechs. Consider the roller-coaster ride experienced by investors in IntraBiotics, maker of an antimicrobial drug that it hopes will prevent a con...</description><pubDate>Wed, 01 Sep 2004 04:01:00 EDT</pubDate></item><item><title>EU Rules to Shake Bioengineered Food</title><link>http://money.cnn.com/2004/04/16/news/international/eu_rules.dj/index.htm</link><guid>http://money.cnn.com/2004/04/16/news/international/eu_rules.dj/index.htm</guid><description>The European Union, one of the major holdouts against genetically modified foods, will start opening the door wider next week, with huge implications for farmers and agricultural companies around the globe as well as European consumers, Friday's Wall Street Journal reported.</description><pubDate>Fri, 16 Apr 2004 10:00:00 EDT</pubDate></item><item><title>Biotech Gets Productive Biopharma companies know how to make cool stuff. Now they are learning how to make a lot of it.</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2003/01/20/335629/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2003/01/20/335629/index.htm</guid><description>The manager of a truck plant faces hard physical limits to how many vehicles his factory can make in a year. But in the blossoming industry of biotech drugs, where production takes place in a ferme...</description><pubDate>Mon, 20 Jan 2003 05:01:00 EST</pubDate></item><item><title>Placing a Bet on Biotech Right now this risky sector             is a bust. That's exactly why I think it's so attractive.</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2002/12/30/334572/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2002/12/30/334572/index.htm</guid><description>I've decided to add a small component of high risk to my IRA, and I can't think of anything riskier than to buy a mutual fund that invests in nothing but biotechnology. I'm not talking about some w...</description><pubDate>Mon, 30 Dec 2002 05:01:00 EST</pubDate></item><item><title>The Next Biohazard</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2002/09/02/327920/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2002/09/02/327920/index.htm</guid><description>Johnson &amp;amp; Johnson stock got hammered in mid-July when the government launched an investigation into its plant in Puerto Rico that makes Eprex, a bioengineered medicine sold outside the U.S. to trea...</description><pubDate>Mon, 02 Sep 2002 04:01:00 EDT</pubDate></item><item><title>China's Biotech Is Starting To Bloom Made-in-China clones, plants, and drugs? The People's Republic has made big steps on the lo</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2002/09/02/327888/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2002/09/02/327888/index.htm</guid><description>Call it a great leapfrog forward: Chinese medicine is jumping into the genomics era while still at one with remedies like bear bile and dried sea horse. Barely three years old, the Beijing Genomics...</description><pubDate>Mon, 02 Sep 2002 04:01:00 EDT</pubDate></item><item><title>Biotech's New Colossus Move over, Big Pharma. Amgen             boasts better growth.</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2002/04/15/321395/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2002/04/15/321395/index.htm</guid><description>For years Amgen has seemed biotechnology's best answer to the likes of Merck--a sector leader with so much heft and momentum that you'd recommend its stock to your mom. But now making that analogy ...</description><pubDate>Mon, 15 Apr 2002 04:01:00 EDT</pubDate></item><item><title>Biotech Grows Up With real profits and a wave of new drugs, it's a sector few investors can ignore anymore.</title><link>http://money.cnn.com/magazines/moneymag/moneymag_archive/2002/03/01/319612/index.htm</link><guid>http://money.cnn.com/magazines/moneymag/moneymag_archive/2002/03/01/319612/index.htm</guid><description>The first wave in biotechnology investing arrived back in the late 1980s, when revolutionary new medicines created by pioneers like Amgen alerted investors to the fledgling sector's potential. The ...</description><pubDate>Fri, 01 Mar 2002 05:01:00 EST</pubDate></item><item><title>Finding The Bulls In Biotech The sector is blazing, the science ever more titillating. But with share prices up 214% in three ye</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2002/02/04/317524/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2002/02/04/317524/index.htm</guid><description>On Dec. 17, Amgen, the flagship company of the biotechnology world, closed the biggest merger in the sector's history. It agreed to pay $16 billion to buy rival Immunex, primarily for the right to ...</description><pubDate>Mon, 04 Feb 2002 05:01:00 EST</pubDate></item><item><title>Bubble, Bubble, Toil And Trouble</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2001/06/11/304605/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2001/06/11/304605/index.htm</guid><description>Grab those white lab coats and protective goggles; biotech doesn't look like the safest place to be right now. Many companies are trading at less than half their 52-week highs. Only three biotechs ...</description><pubDate>Mon, 11 Jun 2001 04:01:00 EDT</pubDate></item><item><title>Reaping A Biotech Blunder Just about everybody ignored the safety rules on a kind of   biotech corn called Starlink. Luckily, no</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2001/02/19/296906/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2001/02/19/296906/index.htm</guid><description>For anyone in the business of growing corn, one of the biggest frustrations of the job is a brown inchworm-like creature that spends most of the summer and fall munching and tunneling through the c...</description><pubDate>Mon, 19 Feb 2001 05:01:00 EST</pubDate></item><item><title>Can Gene Therapy Cure This Child? The money is short and the science controversial, but a lot more than business rides on a biot</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2000/05/01/278933/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2000/05/01/278933/index.htm</guid><description>Loss threatens young biotech companies in more forms than any other kind of business. Investors can lose millions when a promising drug fails to work or funds run out before testing is complete. Re...</description><pubDate>Mon, 01 May 2000 04:01:00 EDT</pubDate></item><item><title>Blessings From The Book of Life Decoding the human genome will yield a bounty of biotech miracles that will transform our lives </title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2000/03/06/275208/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2000/03/06/275208/index.htm</guid><description>In 1998 biotechnology's jauntiest visionary, J. Craig Venter, stunned fellow scientists by declaring that a company he was forming would decode human DNA's sequence of chemical building blocks by t...</description><pubDate>Mon, 06 Mar 2000 05:01:00 EST</pubDate></item><item><title>The Voice of Reason in The Global Food Fight             Rockefeller Foundation chief Gordon Conway has emerged as             t</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2000/02/21/273846/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2000/02/21/273846/index.htm</guid><description>Last June, Gordon Conway, a scholarly British ecologist, walked into the Willard Hotel in Washington, D.C., for a momentous meeting with Monsanto's board. The company had invited him for a private ...</description><pubDate>Mon, 21 Feb 2000 05:01:00 EST</pubDate></item><item><title>Wash That Gray Right Out of Your Hair THE REVIVAL OF GENE THERAPY</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2000/02/07/272841/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2000/02/07/272841/index.htm</guid><description>A breakthrough by a group of researchers in Philadelphia may help reinvigorate the struggling field of gene therapy and portend a future in which Just For Men hair color is history. </description><pubDate>Mon, 07 Feb 2000 05:01:00 EST</pubDate></item><item><title>Why These Biotechs Are As Hot As Net Stocks Wall Street's betting big on a genetic technology that burned it badly before. Monoc</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2000/01/10/271740/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2000/01/10/271740/index.htm</guid><description>Idec Pharmaceuticals, a San Diego biotech company, is hardly a household name. But that's not stopping investors. Its new drug, Rituxan, is rapidly becoming a key weapon in the war against lymphoma...</description><pubDate>Mon, 10 Jan 2000 05:01:00 EST</pubDate></item><item><title>Technology's Promise Our biotech and tech portfolios have turned in top performances.</title><link>http://money.cnn.com/magazines/moneymag/moneymag_archive/1999/11/01/268025/index.htm</link><guid>http://money.cnn.com/magazines/moneymag/moneymag_archive/1999/11/01/268025/index.htm</guid><description>SEPTEMBER '98 "The Biotech Boom" </description><pubDate>Mon, 01 Nov 1999 05:01:00 EST</pubDate></item><item><title>Hatching a DNA Giant It used to take years to find a single gene. Now Millennium Pharmaceuticals, a leader in the booming field </title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1999/05/24/260269/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1999/05/24/260269/index.htm</guid><description>From the look of its stock-price chart, you'd think Millennium Pharmaceuticals was a hot Internet company. Its share price almost quadrupled between September and February--nearly matching Yahoo's ...</description><pubDate>Mon, 24 May 1999 04:01:00 EDT</pubDate></item><item><title>Investing's New Frontier</title><link>http://money.cnn.com/magazines/moneymag/moneymag_archive/1998/09/01/247687/index.htm</link><guid>http://money.cnn.com/magazines/moneymag/moneymag_archive/1998/09/01/247687/index.htm</guid><description>There's a revolution going on. You may know it as cloned mice, or the Human Genome Project, or perhaps insect-resistant corn. It's a revolution with many fronts but one clear quest: unlocking the s...</description><pubDate>Tue, 01 Sep 1998 04:01:00 EDT</pubDate></item><item><title>FINDING NEW LIFE IN HEALTH STOCKS HOW CAN INVESTORS             PROFIT FROM THIS FAST-CHANGING BUT POTENTIALLY LUCRATIVE        </title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1997/09/29/232089/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1997/09/29/232089/index.htm</guid><description>Major demographic shifts, a bulging pipeline of new drugs, expiring patents on existing drugs, fresh questions about the future of managed care--the health-care sector is one of the toughest to pre...</description><pubDate>Mon, 29 Sep 1997 04:01:00 EDT</pubDate></item><item><title>MONSANTO'S BET: THERE'S GOLD IN GOING GREEN CEO ROBERT SHAPIRO THINKS HE CAN FEED THE WORLD'S EXPLODING POPULATION AND HEAL THE </title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1997/04/14/224981/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1997/04/14/224981/index.htm</guid><description>Monsanto CEO Robert Shapiro was ambling through a Sheraton Chicago ballroom at the finale of a three-day company offsite not long ago when an employee named Rebecca Tominack walked up and startled ...</description><pubDate>Mon, 14 Apr 1997 04:01:00 EDT</pubDate></item><item><title>MERCK VS. THE BIOTECH INDUSTRY: WHICH ONE IS MORE POTENT?</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1997/03/31/224060/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1997/03/31/224060/index.htm</guid><description>Since before ovinophiles even thought of altering the genes of their beloved farm animals, people have been putting their hopes into biotechnology stocks. Alas, it hasn't always paid. Over the past...</description><pubDate>Mon, 31 Mar 1997 05:01:00 EST</pubDate></item><item><title>Premium brands, bionic tomatoes, a Bell that rings chimes and a metal that glisters more than gold SMALL STOCK OUTLOOK GET A LOO</title><link>http://money.cnn.com/magazines/moneymag/moneymag_archive/1993/07/01/88152/index.htm</link><guid>http://money.cnn.com/magazines/moneymag/moneymag_archive/1993/07/01/88152/index.htm</guid><description>Want an extremely volatile stock that plunged 39% in the past five months and probably won't turn a profit for two more years? If so, you've come to the right place. Oh, one more thing: The company...</description><pubDate>Thu, 01 Jul 1993 04:01:00 EDT</pubDate></item><item><title>BIOTECH FIRMS TACKLE THE GIANTS Traditional pharmaceutical companies once derided these startups as ''gene jockeys,'' but bold e</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1991/08/12/75355/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1991/08/12/75355/index.htm</guid><description>MENTION drug companies and you'll most likely think of such household names as Merck, Lilly, Johnson &amp;amp; Johnson, or Bristol-Myers Squibb. But some fresh new players are on the brink of glory. After ...</description><pubDate>Mon, 12 Aug 1991 04:01:00 EDT</pubDate></item><item><title>HAVE I GOT A HOT ONE FOR YOU This biotech venture has it all: Glittering scientists, big-name directors, a scheme for fighting a</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1991/04/22/74915/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1991/04/22/74915/index.htm</guid><description>LAST JUNE a biotech company called Icos became the envy of anyone who had ever spliced a gene. Its three founders all had superlative records at their * previous ventures. They also had a fascinati...</description><pubDate>Mon, 22 Apr 1991 04:01:00 EDT</pubDate></item><item><title>THE NEW ATTACK ON KILLER DISEASES There's fresh hope for ailments from cancer to Alzheimer's. Understanding the genetic and mole</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1991/04/22/74916/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1991/04/22/74916/index.htm</guid><description>BUGS -- viruses and bacteria -- cause most minor diseases, and some of the major ones like AIDS. But many of the real killers and cripplers, including cancer, heart disease, rheumatoid arthritis, a...</description><pubDate>Mon, 22 Apr 1991 04:01:00 EDT</pubDate></item><item><title>A PROMISING NEW ASSAULT ON AIDS There's real hope after all: A preventive vaccine could be here by 1993. Other drugs available s</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1990/02/26/73115/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1990/02/26/73115/index.htm</guid><description>AS RECENTLY as last June, some top guns in the war on AIDS seriously doubted that an effective vaccine against it could ever be found. The human immunodeficiency virus (HIV) that causes the deadly ...</description><pubDate>Mon, 26 Feb 1990 05:01:00 EST</pubDate></item><item><title>BRINGING BIOTECH DOWN TO EARTH Suddenly the hot companies that make wonder drugs face formidable competition in the race from re</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1988/11/07/71237/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1988/11/07/71237/index.htm</guid><description>WALL STREET is sending a persistent message to its onetime favorites, the health biotech companies: You don't have the kind of future you thought you had. Some of you figured you would turn into th...</description><pubDate>Mon, 07 Nov 1988 05:01:00 EST</pubDate></item><item><title>GENENTECH HAS A GOLDEN GOOSE The blood-clot-busting drug t-PA is throwing off profits that will underwrite a host of new product</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1988/05/09/70518/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1988/05/09/70518/index.htm</guid><description>NOT BAD FOR a company that began life a dozen years ago when a scientist and a young MBA put up $500 apiece: Genentech Inc. now has nine low-slung, crowded buildings on breezy Point San Bruno, whic...</description><pubDate>Mon, 09 May 1988 04:01:00 EDT</pubDate></item><item><title>STRIKING IT RICH IN BIOTECH The brainy scientists who founded companies to turn out genetically engineered products had to learn</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1987/11/09/69810/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1987/11/09/69810/index.htm</guid><description>OF ALL THE REASONS bright people once chose careers in biology, getting rich surely was not one of them. The challenge of unraveling life's deepest mysteries -- and the tantalizing chance for a Nob...</description><pubDate>Mon, 09 Nov 1987 05:01:00 EST</pubDate></item><item><title>HERE COME THE BIONIC PIGLETS Companies are finally translating the promise of biotechnology into the first farm and industrial p</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1987/10/26/69721/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1987/10/26/69721/index.htm</guid><description>YOU'VE HEARD the band music and the rest of the hoopla about the high-powered health products turned out by genetic engineering -- a cornucopia that ranges from new vaccines to promising drugs for ...</description><pubDate>Mon, 26 Oct 1987 05:01:00 EST</pubDate></item><item><title>THE BIG BOYS ARE JOINING THE BIOTECH PARTY Corporate giants are about to crowd the start-ups. Reason: Despite Genentech's setbac</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1987/07/06/69229/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1987/07/06/69229/index.htm</guid><description>IT WAS a moment of high drama for America's promising young biotechnology industry. And it unfolded theatrically before a disbelieving audience of more than 400 health care executives, Wall Street ...</description><pubDate>Mon, 06 Jul 1987 04:01:00 EDT</pubDate></item><item><title>WILL BIOTECH'S BOOM GO BUST? The prospect of big profits has sent the stocks on a tear, but analysts fear that many have gone to</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1987/07/06/69213/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1987/07/06/69213/index.htm</guid><description>Firms in the far-out field of genetic engineering have long been high on promise and short on profits. Now, after years of painstaking development, they are poised for the payoff. The product pipel...</description><pubDate>Mon, 06 Jul 1987 04:01:00 EDT</pubDate></item><item><title>COMING: STAR WARS MEDICINE Monoclonal antibodies, derived from the body's immune system, not only speed diagnosis but also deliv</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1987/04/27/68945/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1987/04/27/68945/index.htm</guid><description>IN THE CLOSELY WATCHED arena of biotechnology, the spotlight so far has been on genetic engineering -- tinkering with the genetic blueprints of living things to try to devise exciting new products,...</description><pubDate>Mon, 27 Apr 1987 04:01:00 EDT</pubDate></item><item><title>MERCK HAS MADE BIOTECH WORK The company changed its methods of doing research in the Seventies. The result -- a shelf's worth of</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1987/01/19/68590/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1987/01/19/68590/index.htm</guid><description>HOLLYWOOD honors its stars by casting their footprints in cement. Wall Street firms put portraits of their founders in gilt frames. But at the New Jersey headquarters of Merck &amp;amp; Co., office corrido...</description><pubDate>Mon, 19 Jan 1987 05:01:00 EST</pubDate></item><item><title>COVER THE YEAR'S 50 MOST FASCINATING BUSINESS PEOPLE ROBERT SWANSON THE MAN WHO COULD MAKE BIOTECHNOLOGY PROFITABLE -- AT LAST</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1987/01/05/68495/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1987/01/05/68495/index.htm</guid><description>THE VISIONARY who did most to turn the arcane genetic engineering revolution into a new industry is an unimpressive-looking fellow. But behind that unprepossessing exterior, Robert A. Swanson, 39, ...</description><pubDate>Mon, 05 Jan 1987 05:01:00 EST</pubDate></item><item><title>WHERE THE U.S. STANDS COMPUTERS, CHIPS, AND FACTORY AUTOMATION</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1986/10/13/68154/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1986/10/13/68154/index.htm</guid><description>IN THE HEADLONG RUSH of high technology, the driving force has been the computer and everything connected with it -- semiconductor chips, robots, telecommunications. By the year 2000 the electronic...</description><pubDate>Mon, 13 Oct 1986 04:01:00 EDT</pubDate></item><item><title>Looking for the Biotech Blockbusters</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1986/07/07/67796/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1986/07/07/67796/index.htm</guid><description>For all the oohs and ahs about gene-splicing feats in the lab, biotechnology has delivered next to nothing in the way of bankable profits. Lately, though, wondrous discoveries have begun making the...</description><pubDate>Mon, 07 Jul 1986 04:01:00 EDT</pubDate></item><item><title>A shot in the arm for biotechnology</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1986/07/07/67839/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1986/07/07/67839/index.htm</guid><description>Hairy cell leukemia is a rare form of cancer that affects about 2,000 Americans. But in approving alpha interferon in early June to treat the disease, the Food and Drug Administration has given bio...</description><pubDate>Mon, 07 Jul 1986 04:01:00 EDT</pubDate></item><item><title>Setbacks for Biotech</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1986/04/28/67503/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1986/04/28/67503/index.htm</guid><description>When Advanced Genetic Sciences, a tiny biotechnology company, got the first Environmental Protection Agency permit to test genetically engineered bacteria outdoors, environmentalists protested that...</description><pubDate>Mon, 28 Apr 1986 04:01:00 EDT</pubDate></item><item><title>THE NEW ASSAULT ON HEART ATTACKS The across-the-board approach to prevention through diet and exercise is giving way to medical </title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1986/03/31/67325/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1986/03/31/67325/index.htm</guid><description>BY NOW MANY health-conscious Americans can readily reel off the four main risk factors commonly associated with heart disease: a high cholesterol level, a diet heavy in saturated fats, high blood p...</description><pubDate>Mon, 31 Mar 1986 05:01:00 EST</pubDate></item><item><title>BACTERIA UNBOUND Protesters want to keep mutant microbes off the farm.</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1986/02/17/67139/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1986/02/17/67139/index.htm</guid><description>A SMALL CALIFORNIA biotechnology company is battling for the right to be first in the world to test genetically engineered bacteria outdoors, where the mutants might be free to roam. Advanced Genet...</description><pubDate>Mon, 17 Feb 1986 05:01:00 EST</pubDate></item><item><title>THE YEAR'S 50 MOST FASCINATING BUSINESS PEOPLE ROBERT SWANSON THE MAN WHO COULD MAKE BIOTECHNOLOGY PROFITABLE -- AT LAST</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1986/01/05/66856/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1986/01/05/66856/index.htm</guid><description>THE VISIONARY who did most to turn the arcane genetic engineering revolution into a new industry is an unimpressive-looking fellow. But behind that unprepos-sessing exterior, Robert A. Swanson, 39,...</description><pubDate>Sun, 05 Jan 1986 05:01:00 EST</pubDate></item><item><title>TEST-TUBE PLANTS HIT PAY DIRT Exotic genetic-engineering techniques were supposed to remake agriculture. But shrewd businessmen-</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1985/09/02/66387/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1985/09/02/66387/index.htm</guid><description>AGRICULTURAL biotechnology is finally emerging from a miasma of wild-eyed claims and promises that have swathed it in recent years. After researchers at the Max Planck Institute in West Germany suc...</description><pubDate>Mon, 02 Sep 1985 04:01:00 EDT</pubDate></item></channel></rss>